Expertise in
11
conditions

Daniele Raggi

Milan, IT 
Expertise in
11
conditions
Milan, IT 
OverviewLocationsClinical Research

Overview

Daniele Raggi practices in Milan, Italy. Ms. Raggi is highly rated in 11 conditions, according to our data. Her top areas of expertise are Urothelial Cancer, Bladder Cancer, Penile Cancer, Cystectomy, and Nephrectomy.

Her clinical research consists of co-authoring 148 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Milan, Italy
Other Locations
Messina, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Open-label, Single-arm, Phase II Study, Evaluating Safety and Efficacy of INCB054828 (Pemigatinib) as Adjuvant Therapy for Molecularly-selected, High-risk Patients With Urothelial Carcinoma Who Have Received Radical Surgery
Open-label, Single-arm, Phase II Study, Evaluating Safety and Efficacy of INCB054828 (Pemigatinib) as Adjuvant Therapy for Molecularly-selected, High-risk Patients With Urothelial Carcinoma Who Have Received Radical Surgery
Enrollment Status: Terminated
Publish Date: April 18, 2025
Intervention Type: Drug
Study Drug: Pemigatinib
Study Phase: Phase 2
An Open Label, Single-arm, Phase 2 Study of Pembrolizumab and Nanoparticle Albumin-bound Paclitaxel in Patients With Metastatic Urothelial Carcinoma After Chemotherapy Failure; the PEANUT Study
An Open Label, Single-arm, Phase 2 Study of Pembrolizumab and Nanoparticle Albumin-bound Paclitaxel in Patients With Metastatic Urothelial Carcinoma After Chemotherapy Failure; the PEANUT Study
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

148 Total Publications

HER2 and urothelial carcinoma: current understanding and future directions.
HER2 and urothelial carcinoma: current understanding and future directions.
Journal: Nature reviews. Urology
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Raggi's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile